BioWorld MedTech

May 31, 2012

The MDD Interview: Hoping that benefits, needs can carry the day for new products

Robert Ward is chairman of Emergence Venture Partners, president of ExThera Medical (both Berkeley, California), and founder and former president of the Polymer Technology Group (PTG), now DSM Biomedical. Read More

ViewRay gains clearance for MRI guided radiation therapy system

Washington roundup: House passes FDA user fee legislation with voice vote

Agreements/contracts: Spacelabs provides solutions to Texas hospital department

Financings roundup: Kona Medical raises $30M in 'C' round of financing

Patents roundup: Miracor strengthens patent protection for PICSO in U.S.

International report: Symmetry to drive expansion in Australia and New Zealand

Product Briefs

HIT roundup: HL7 recruiting physicians to bolster EHR standards

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...